Intensity of warfarin coagulation in the antiphospholipid syndrome

被引：8
|
作者：
Crowther M.A. [1 ]
机构：
[1] Division of Hematology and Thromboembolism, McMaster University, St Joseph's Hospital, 50 Charlton Ave, East Hamilton, ON
来源：
Current Rheumatology Reports | 2010年 / 12卷 / 1期
关键词：
Anticoagulation; Antiphospholipid syndrome; Lupus anticoagulant; Warfarin;
D O I：
10.1007/s11926-009-0070-9
中图分类号：
学科分类号：
摘要：
Antiphospholipid syndrome is a condition with an increased propensity for both arterial and venous thrombosis. Compared with the normal population there is also a higher rate of recurrence. Most evidence exists for the use of warfarin in the secondary prevention of thromboembolism, aiming for an international normalized ratio between 2.0 and 3.0. Care must be taken with all anticoagulants because of the increased risk of bleeding. Several other strategies are available if warfarin fails, including the addition of aspirin, increasing the warfarin target range, and use of heparin. © 2010 Springer Science+Business Media, LLC.
引用
收藏
页码：64 / 69
页数：5
相关论文
共 50 条
  • [41] Antiphospholipid antibodies and physiological coagulation inhibitors in ''recurrent abortions syndrome''
    Mazzucconi, MG
    Peraino, M
    Chistolini, A
    Dragoni, F
    Bernasconi, S
    Paesano, R
    Glorgetti, T
    Masala, C
    DeStefano, V
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2184 - P2184
  • [42] The Pathophysiology of The Antiphospholipid Syndrome: A Perspective From The Blood Coagulation System
    Arreola-Diaz, R.
    Majluf-Cruz, A.
    Sanchez-Torres, L. E.
    Hernandez-Juarez, J.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [43] The Pathophysiology of The Antiphospholipid Syndrome: A Perspective From The Blood Coagulation System
    Arreola-Diaz, R.
    Majluf-Cruz, A.
    Sanchez-Torres, L. E.
    Hernandez-Juarez, J.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [44] Warfarin reversal in patients with antiphospholipid syndrome: Caution required, but clear guidance not available
    Badami, Krishna G.
    Faed, James M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [45] Thrombin generation testing to monitor warfarin anticoagulation in thrombotic antiphospholipid syndrome patients
    Efthymiou, M.
    Lawrie, A. S.
    Mackie, I. J.
    Machin, S. J.
    Cohen, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 962 - 962
  • [46] Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome
    Giarretta, Igor
    Ageno, Walter
    Dentali, Francesco
    HAEMATOLOGICA, 2022, 107 (11) : 2737 - 2741
  • [47] Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial
    Woller, Scott C.
    Stevens, Scott M.
    Kaplan, David
    Wang, Tzu-Fei
    Branch, D. Ware
    Groat, Danielle
    Wilson, Emily L.
    Armbruster, Brent
    Aston, Valerie T.
    Lloyd, James F.
    Rondina, Matthew T.
    Elliott, C. Greg
    BLOOD ADVANCES, 2022, 6 (06) : 1661 - 1670
  • [48] Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome
    Giarretta, Igor
    Ageno, Walter
    Dentali, Francesco
    HAEMATOLOGICA, 2022, 107 : 2737 - 2741
  • [49] Cutaneous necrosis in patient with antiphospholipid syndrome successfully treated with topical pimecrolimus and warfarin
    Bianchi, Leonardo
    Sensini, Chiara
    Hansel, Katharina
    Tramontana, Marta
    Romita, Paolo
    Giuffrida, Roberta
    Stingeni, Luca
    DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [50] Comparison of the Therapeutic Effects of Rivaroxaban Versus Warfarin in Antiphospholipid Syndrome: A Systematic Review
    Khodashahi, Mandana
    Rezaieyazdi, Zahra
    Sahebari, Maryam
    ARCHIVES OF RHEUMATOLOGY, 2020, 35 (01) : 107 - 116
12345